Viagra — Melanoma MDL Might Include Cialis Lawsuits And Levitra Cases

As regards drug injury lawsuits concerning the melanoma side effect of male erectile dysfunction (ED) pills, that litigation began with Viagra cases being filed against Pfizer, the drug company responsible for Viagra. By April 2016 there was a sufficient federal court Viagra lawsuits filed that the Judicial Panel on Multidistrict Litigation (JPML) decided to create the so-called Viagra MDL, known fully as IN RE: VIAGRA (SILDENAFIL CITRATE) PRODUCTS LIABILITY LITIGATION — MDL №2691. This federal court consolidation of Viagra lawsuits was assigned to Judge Richard Seeborg, of the Northern District of California. To date, more than 200 Viagra cases are pending before Judge Seeborg in San Francisco related to individuals being diagnosed with melanoma after using Viagra.

Not unexpectedly, the filing of Viagra lawsuits has been followed by the filing of Cialis lawsuits on behalf of men who have developed malignant melanoma, some of whom have died, unfortunately.

In September 2016 the plaintiffs in some of those federal court Cialis cases asked the JPML to add their lawsuits to the Viagra MDL for various reasons, including the need for judicial economy, consistency in rulings, and the commonality among the Viagra and Cialis melanoma claims. That motion for what would then be a Viagra — Cialis MDL is currently pending.

Next, it is likely that there will be Levitra — melanoma lawsuits filed in the next few months. And, further, once the number of Levitra cases filed in federal court reaches a certain level, one anticipates a motion filed with the JPML requesting that those melanoma cases get added to an expanded federal court Viagra MDL.

We are currently investigating cases of melanoma in men who used Viagra, Cialis, and/or Levitra. These cases are possible drug injury lawsuits against the responsible pharmaceutical companies, not the prescribing doctors.

[Read this article in full at original source]

Show your support

Clapping shows how much you appreciated Thomas Lamb’s story.